Appendix G.

Subanalyses of patients diagnosed 2009–2011 (balanced by year) IPTW-adjusted overall and RCC-specific survival at 1 and 3 years, by treatment type among patients diagnosed 2009–2011.

	PA % (95% CI)	PN % (95% CI)	PA % (95% CI)	RN % (95% CI)
	RSS
1-year	99 (99–100)	100 (99–100)	99 (99–100)	99 (98–99)
3-year	98 (96–100)	99 (98–100)	98 (97–100)	96 (95–98)
OS
1-year	96 (95–98)	98 (97–98)	95 (93–97)	94 (93–96)
3-year	90 (87–93)	94 (92–95)	87 (84–90)	86 (83–88)

Notes:

-Survival probabilities generated from an Inverse Probability of Treatment-Weighted (IPTW) Cox model with a time-dependent treatment variable

-First two columns give survival probabilities for PA-PN matched cohorts; second two columns give survival probabilities for PA-RN matched cohorts.

-RCC, renal cell carcinoma; RSS, RCC-specific survival; OS, overall survival; PA, percutaneous ablation; PN, partial nephrectomy; RN, radical nephrectomy

-Results are essentially the same as those from primary analysis